TY - JOUR
T1 - Sudden cardiac death after acute decompensation in heart failure patients
T2 - implications of discharge haemoglobin levels
AU - Fukuoka, Ryoma
AU - Kohsaka, Shun
AU - Shiraishi, Yasuyuki
AU - Sawano, Mitsuaki
AU - Abe, Takayuki
AU - Levy, Wayne C.
AU - Nagatomo, Yuji
AU - Nishihata, Yosuke
AU - Goda, Ayumi
AU - Kono, Takashi
AU - Kawamura, Akio
AU - Fukuda, Keiichi
AU - Yoshikawa, Tsutomu
N1 - Funding Information:
S.K. received an unrestricted research grant for the Department of Cardiology, Keio University School of Medicine, from Bayer Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Novartis Pharma Co., Ltd. Y.S. is affiliated with an endowed department by Nippon Shinyaku Co., Ltd., Medtronic Japan Co., Ltd., and BIOTRONIK JAPAN Inc., and received research grants from the SECOM Science and Technology Foundation and the Uehara Memorial Foundation and honoraria from Otsuka Pharmaceuticals Co., Ltd., and Ono Pharmaceuticals Co., Ltd. W.C.L. is a member of the Steering Committee; Cardiac Dimensions, Respicardia and Clinical Endpoint Committee: Abbott, Siemens, Beckman Coulter and EBR Systems. He is a consultant to Medtronic and Impulse Dynamics. Other authors have no conflicts of interest to disclose. There are no patents, products in development or marketed products to declare. Seattle Proportional Risk Model copyright is owned by the University of Washington CoMotion.
Funding Information:
This study was supported by Grant‐in‐Aid for Young Scientists (JPSS KAKENHI, 18K15860 [Y.S.]), Grant‐in‐Aid for Scientific Research (23591062, 26461088 [T.Y.], 17K09526 [T.K.], 20H03915 [S.K.]), the Sakakibara Clinical Research Grant for Promotion of Sciences (2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020 [T.Y.]) and Grant from the Japan Agency for Medical Research and Development (201439013C [S.K.]). SPRM and SHFM copyrights are held by, and licensing fees are paid to University of Washington CoMotion.
Funding Information:
This study was supported by Grant-in-Aid for Young Scientists (JPSS KAKENHI, 18K15860 [Y.S.]), Grant-in-Aid for Scientific Research (23591062, 26461088 [T.Y.], 17K09526 [T.K.], 20H03915 [S.K.]), the Sakakibara Clinical Research Grant for Promotion of Sciences (2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020 [T.Y.]) and Grant from the Japan Agency for Medical Research and Development (201439013C [S.K.]). SPRM and SHFM copyrights are held by, and licensing fees are paid to University of Washington CoMotion.
Publisher Copyright:
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
PY - 2021/10
Y1 - 2021/10
N2 - Aims: Heart failure (HF) patients have a high risk of mortality due to sudden cardiac death (SCD) and non-SCD, including pump failure death (PFD). Anaemia predicts more severe symptomatic burden and higher morbidity, as noted by markedly increased hospitalizations and readmission rates, and mortality, underscoring its importance in HF management. Herein, we aimed to determine whether haemoglobin (Hb) level at discharge affects the mode of death and influences SCD risk prediction. Methods: We evaluated the data of 3020 consecutive acute HF patients from a Japanese prospective multicentre registry. Patients were divided into four groups based on discharge Hb levels. SCD was defined as an unexpected and otherwise unexplained death in a previously stable patient or death due to documented or presumed cardiac arrhythmia without a clear non-cardiovascular cause. The mode of death (SCD, PFD or other cause) was adjudicated by a central committee. Finally, we investigated whether adding Hb level to the Seattle Proportional Risk Model (SPRM; established risk score utilized to estimate ‘proportion’ of SCD among death events) would affect its performance. Results: The mean age of studied patients was 74.3 ± 12.9 years, and 59.8% were male. The mean Hb level was 12.0 ± 2.1 g/dL (61.3% of patients had anaemia defined by World Health Organization criteria). During the 2-year follow-up, 474 deaths (15.7%) occurred, including 93 SCDs (3.1%), 171 PFDs (5.7%) and 210 other deaths (7.0%; predominantly non-cardiac death). Absolute risk of PFD (P < 0.001) or other death (P < 0.001) increased along with the severity of anaemia, whereas the incidence of SCD was low but remained consistent across all four groups (P = 0.440). As a proportion of total deaths in each Hb level group, the contributions from non-SCD increased and from SCD decreased along with anaemia severity (P = 0.007). Adding Hb level to the SPRM improved the overall discrimination (c-index: 0.62 [95% confidence interval (CI) 0.56–0.69] to 0.65 [95% CI 0.59–0.71]), regardless of the baseline ejection fraction (EF) (c-index: 0.64 [95% CI 0.55–0.73] to 0.67 [95% CI 0.58–0.75] for reduced EF and 0.55 [95% CI 0.45–0.66] to 0.61 [95% CI 0.52–0.70] for preserved EF). Conclusions: The discharge Hb level provides information about both absolute and proportional risks for each mode of death in acute HF patients, and the addition of Hb level improves the performance of SPRM by identifying more non-SCD cases. Future ‘proportional’ SCD risk models should incorporate Hb level as a covariate to meet this high performance.
AB - Aims: Heart failure (HF) patients have a high risk of mortality due to sudden cardiac death (SCD) and non-SCD, including pump failure death (PFD). Anaemia predicts more severe symptomatic burden and higher morbidity, as noted by markedly increased hospitalizations and readmission rates, and mortality, underscoring its importance in HF management. Herein, we aimed to determine whether haemoglobin (Hb) level at discharge affects the mode of death and influences SCD risk prediction. Methods: We evaluated the data of 3020 consecutive acute HF patients from a Japanese prospective multicentre registry. Patients were divided into four groups based on discharge Hb levels. SCD was defined as an unexpected and otherwise unexplained death in a previously stable patient or death due to documented or presumed cardiac arrhythmia without a clear non-cardiovascular cause. The mode of death (SCD, PFD or other cause) was adjudicated by a central committee. Finally, we investigated whether adding Hb level to the Seattle Proportional Risk Model (SPRM; established risk score utilized to estimate ‘proportion’ of SCD among death events) would affect its performance. Results: The mean age of studied patients was 74.3 ± 12.9 years, and 59.8% were male. The mean Hb level was 12.0 ± 2.1 g/dL (61.3% of patients had anaemia defined by World Health Organization criteria). During the 2-year follow-up, 474 deaths (15.7%) occurred, including 93 SCDs (3.1%), 171 PFDs (5.7%) and 210 other deaths (7.0%; predominantly non-cardiac death). Absolute risk of PFD (P < 0.001) or other death (P < 0.001) increased along with the severity of anaemia, whereas the incidence of SCD was low but remained consistent across all four groups (P = 0.440). As a proportion of total deaths in each Hb level group, the contributions from non-SCD increased and from SCD decreased along with anaemia severity (P = 0.007). Adding Hb level to the SPRM improved the overall discrimination (c-index: 0.62 [95% confidence interval (CI) 0.56–0.69] to 0.65 [95% CI 0.59–0.71]), regardless of the baseline ejection fraction (EF) (c-index: 0.64 [95% CI 0.55–0.73] to 0.67 [95% CI 0.58–0.75] for reduced EF and 0.55 [95% CI 0.45–0.66] to 0.61 [95% CI 0.52–0.70] for preserved EF). Conclusions: The discharge Hb level provides information about both absolute and proportional risks for each mode of death in acute HF patients, and the addition of Hb level improves the performance of SPRM by identifying more non-SCD cases. Future ‘proportional’ SCD risk models should incorporate Hb level as a covariate to meet this high performance.
KW - Anaemia
KW - Haemoglobin level
KW - Heart failure
KW - Risk prediction model
KW - Sudden cardiac death
UR - http://www.scopus.com/inward/record.url?scp=85111520189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111520189&partnerID=8YFLogxK
U2 - 10.1002/ehf2.13414
DO - 10.1002/ehf2.13414
M3 - Article
C2 - 34323007
AN - SCOPUS:85111520189
SN - 2055-5822
VL - 8
SP - 3917
EP - 3928
JO - ESC Heart Failure
JF - ESC Heart Failure
IS - 5
ER -